Anti-PEG Single-Chain Variable-Fragment Antibody-Assisted <i>In Vivo</i> Process Decoding of PEGylated Nanomedicines
processes of nanomedicines to establish dose-effect relationships like small-molecule drugs, further to guide rational nanotherapeutic design.
Authors
- Changyou Zhan (ORCID: https://orcid.org/0000-0002-5215-2829)
- Jun Qian (ORCID: https://orcid.org/0009-0001-8131-9704)
- Gan Luo (ORCID: https://orcid.org/0000-0003-3325-3736)
- Yawen Qi
- Qi Xu (ORCID: https://orcid.org/0000-0002-6512-0631)
- Tianlei Ying (ORCID: https://orcid.org/0000-0002-9597-2843)
- Yinyu Ma
- Zhenlin Yang
- Kuan Jiang (ORCID: https://orcid.org/0009-0002-7036-1517)
- Feng Pan
- Kaisong Tian
Institutions
- Fudan University (CN)
- Department of Virology (FR)
- Ministry of Education (KR)
- Quzhou University (CN)
- Zhongshan Hospital (CN)
- Pudong Medical Center (CN)
- Inflammation Research Foundation (US)
- Synthetic Biologics (United States) (US)
- He Eye Hospital (CN)
Publication Details
- Journal
- ACS Nano
- Published
- 2026-07-26
- DOI
- https://doi.org/10.1021/acsnano.6c09408
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00